Abstract THE DEVELOPMENT OF more cost-effective light sources for photodynamic
therapy of brain tumors would be of benefit for both research and clinical applications. In this …

✓ Photodynamic therapy was studied in dogs with and without posterior fossa
glioblastomas. This mode of therapy consisted of intravenous administration of Photofrin-II at …

Background and Objectives PDT has been used in the treatment of malignant brain tumors.
This communication updates our series of unselected malignant gliomas treated with …

Introduction: Photodynamic therapy (PDT) involves the selective retention of a
photosensitizer that upon activation with light mediates tumor cell destruction via the …

Abstract Background and Objective: The reactive oxygen mechanisms associated with cell
damage after photodynamic therapy (PDT) may be exploited to enhance tumor destruction …

In a phase II trial we treated more than 100 patients with malignant brain tumors with 2-
mg/kg Photofrin iv. and intraoperative cavitary PDT. We concluded that PDT was safe in …

Abstract Background and Objectives Intra‐operative identification of tumor by fluorescence
may improve surgical resection or photodynamic therapy (PDT). A novel instrument was …

Aim: Photodynamic therapy (PDT) appears to be a valuable new treatment modality for
cancer therapy. Studies have reported successful application of PDT for glioblastoma. Here …

Abstract Background and Objective Liposomes as photosensitizer carriers may enhance the
photodynamic effect on tumors. Study Design/Materials and Methods: To test this …

In this study we investigated the influence of Photofrin-based photodynamic therapy (PDT)
on the migration of two human glioma cell lines in vitro. U87 and U25ln tumour cells were …